The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2Lauren Stevenson(American College of Physician Executives), Mark K. Saville(University of Dundee)The EMBO JournalFebruary 8, 200710.1038/sj.emboj.7601567Cited by 278SaveCiteExport RISWatch citationsRelated Papers2018 White Paper on Recent Issues in Bioanalysis: Focus on Flow Cytometry, Gene Therapy, Cut Points and Key Clarifications on Bav (Part 3 – Lba/Cell-Based Assays: Immunogenicity, Biomarkers and Pk Assays)|Bioanalysis|2018|53The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a|Oncogene|2013|46